Analyst Ratings for Jazz Pharmaceuticals (JAZZ) [Buys]
JAZZ Rating Summary
JAZZ Price Target Summary
- Highest: $86.00 (Cantor Fitzgerald)
- Lowest: $40.00 (WBB Securities)
- Average: $68.50
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$68.50 (+0.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/31/2013 | Stifel Nicolaus | New Coverage | Buy (N/A) |
80.00 (N/A) |
68.44 | 68.28 | -0.23% | Details |
| 3/28/2013 | JMP Securities | New Coverage | Market Outperform (N/A) |
66.00 (N/A) |
56.42 | 68.28 | 21.02% | Details |
| 3/11/2013 | Cantor Fitzgerald » Updated 5/31/2013 |
New Coverage | Buy (N/A) |
86.00 (N/A) |
58.50 | 68.28 | 16.72% | Details |
| 11/29/2012 | UBS » Updated 2/27/2013 |
New Coverage | Buy (N/A) |
67.00 (64.00) |
51.07 | 68.28 | 33.7% | Details |
| 11/27/2012 | Citi | New Coverage | Buy (N/A) |
70.00 (N/A) |
51.85 | 68.28 | 31.69% | Details |
| 9/27/2012 | Brean Capital | New Coverage | Buy (N/A) |
81.00 (N/A) |
54.79 | 68.28 | 24.62% | Details |
| 9/18/2012 | Guggenheim » Updated 5/22/2013 |
New Coverage | Buy (N/A) |
69.00 (N/A) |
55.29 | 68.28 | 23.49% | Details |
| 9/11/2012 | Cowen | Upgrade | Outperform (Neutral) |
N/A (N/A) |
43.56 | 68.28 | 56.75% | Details |
| 8/27/2012 | WallachBeth Capital | New Coverage | Buy (N/A) |
63.00 (N/A) |
46.50 | 68.28 | 46.84% | Details |
| 6/21/2012 | Barclays » Updated 9/18/2012 |
New Coverage | Overweight (N/A) |
60.00 (N/A) |
46.03 | 68.28 | 48.34% | Details |
| 5/23/2012 | Credit Suisse | New Coverage | Outperform (N/A) |
65.00 (N/A) |
43.66 | 68.28 | 56.39% | Details |
| 5/23/2012 | Oppenheimer » Updated 9/28/2012 |
New Coverage | Outperform (N/A) |
66.00 (66.00) |
43.66 | 68.28 | 56.39% | Details |
| 4/13/2012 | Leerink Swann » Updated 9/11/2012 |
New Coverage | Outperform (N/A) |
70.00 (N/A) |
44.64 | 68.28 | 52.96% | Details |
| 9/30/2011 | Auriga » Updated 5/9/2012 |
New Coverage | Buy (N/A) |
64.00 (N/A) |
41.68 | 68.28 | 63.82% | Details |
| 8/1/2011 | Jefferies » Updated 4/27/2012 |
Upgrade | Buy (N/A) |
74.00 (N/A) |
40.47 | 68.28 | 68.72% | Details |
